XARELTO®: Initial treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

Patients with VTE are complex.1-3 Helping protect them against thrombosis doesn’t have to be.

DVT/PE DOSING 30-day Starter Pack

DVT/PE EFFICACY Proven efficacy in the initial treatment of DVT/PE1,2

DVT/PE SAFETY Proven safety profile in initial treatment of DVT/PE1,2

DVT/PE CLINICAL TRIALS Dedicated DVT and PE trials1,2

VTE PLATFORM 6 indications to treat and help protect from a VTE—both inpatient and outpatient*1,2,5-9

JANSSEN CAREPATH XARELTO® Savings Program

FORMULARY FINDER Coverage for your patients

Initial DVT/PE Resources

DOSING ACROSS INDICATIONS Condition-specific dosing for XARELTO®

EINSTEIN DVT/PE REPRINT Prins MH et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN–DVT and PE randomized studies

DVT/PE STARTER PACK Initiate treatment with a
30-day prescription

View all resources

*The decision regarding initiation setting should be based on the prescriber's clinical judgment.

DVT = deep vein thrombosis; PE = pulmonary embolism; VTE = venous thromboembolism.

References: 1. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e195Se226S. doi:10.1378/chest.11-2296 2. Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-4738. doi:10.1182/ bloodadvances.2020001830 3. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S-e325S. doi:10.1378/ chest.11-2404